1. Home
  2. CBIO vs SHOE Comparison

CBIO vs SHOE Comparison

Compare CBIO & SHOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crescent Biopharma Inc.

CBIO

Crescent Biopharma Inc.

HOLD

Current Price

$16.86

Market Cap

482.6M

Sector

N/A

ML Signal

HOLD

SHOE

Shoe Station Group Inc. Common Stock

N/A

Current Price

$15.17

Market Cap

433.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
CBIO
SHOE
Founded
2003
N/A
Country
United States
United States
Employees
44
5000
Industry
Clothing/Shoe/Accessory Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
482.6M
433.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CBIO
SHOE
Price
$16.86
$15.17
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$26.67
N/A
AVG Volume (30 Days)
313.1K
604.8K
Earning Date
04-29-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$279.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.72
$14.79
52 Week High
$27.41
$16.29

Technical Indicators

Market Signals
Indicator
CBIO
SHOE
Relative Strength Index (RSI) 42.88 39.36
Support Level $17.02 N/A
Resistance Level $19.05 $16.20
Average True Range (ATR) 1.26 0.66
MACD -0.01 -0.08
Stochastic Oscillator 21.77 20.00

Price Performance

Historical Comparison
CBIO
SHOE

About CBIO Crescent Biopharma Inc.

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

About SHOE Shoe Station Group Inc. Common Stock

Shoe Station Group Inc is a one-stop family footwear destination that offers an impressive selection from top brands. It is a fashion destination for footwear, southern-inspired accessories, and apparel. The group has physical stores throughout five Southern states and is available online at ShoeStation.com, shipping all across the U.S. Its offer products for Women's, Men's, and Kids.

Share on Social Networks: